BUSINESS
US FDA plant observations at Cipla cause 6-month delay in product launches: CEO
The biggest product under manufacture in the Pithampur facility is Advair which has a market size of $700 million
BUSINESS
MediBuddy eyes mental health-focused ventures for acquisitions: CEO
The management expects the company’s core business to turn profitable by March 2024
HEALTH-AND-FITNESS
Breaking Bad: Osteoporosis, or the silent sound of India’s crumbling bones
In the Indian population, the age of onset of this degenerative bone disease is a few years earlier than in the western population
TRENDS
India’s low-cost blood cancer therapy to roll out in two months
Laurus Labs holds a 34 percent stake in the startup which has developed the product
BUSINESS
Sun Pharma subsidiary recalls anti-depression drugs in US market
The recall was reported in the daily U.S. Food and Drug Administration Recall Information updates
BUSINESS
Pharma industry to observe Good Manufacturing Practices Day on October 10
The day will be marked by conducting training and sensitisation sessions for quality control staff in manufacturing companies and for pharmacy students
BUSINESS
General insurance industry premium rises 29% in September
Health insurance premium rose 23 percent in the month of September
BUSINESS
Zydus, Aurobindo subsidiaries recall drugs in the US market
The recalls were reported in the daily U.S. Food and Drug Administration Recall Information updates
BUSINESS
Dr Reddy’s to set up subsidiary for nutraceuticals, supplements
In July, the company forayed into child nutrition with the launch of CeleHealth Kidz Immuno Plus Gummies in the Indian market
TRENDS
US study says air pollution ups chances of breast cancer: Is India at risk?
Indian oncologists say that the conclusion of the study is not entirely unexpected, as particulate matter is already associated with increased risk of lung cancer
BUSINESS
After API subsidiary sale, Glenmark aims to check R&D spends, expand margins
The company’s R&D expenditure will come down to 7-7.5 percent of sales after the disinvestment in Glenmark Lifesciences. It was virtually double, at 14.2 percent of sales, in FY 17-18
BUSINESS
Glenmark Life Sciences deal to reduce parent’s debt, make it net cash positive: CMD
Saldhana added that the management of Glenmark Lifesciences will remain intact
INDIA
NEET PG 2023 cut-off reduced to zero for all categories
IMA had requested the Health Minister for the same a few days ago
INDIA
Nipah in Kerala from Bangladesh variant: State health minister
The state health minister also said that the doctors of the patients currently under treatment have requested for monoclonal antibodies from ICMR- NIV for treatment
INDIA
Nipah virus in India: Six outbreaks since 2001
The Union Health Ministry has confirmed that the two people who recently died in Kerala's Kozhikode due to “unnatural fever” were infected by the Nipah virus.
INDIA
The silent crisis: Student suicides rise 70% in a decade in India
Exams, the education system, COVID-19, and social media are some of the factors blamed for this scenario. The government and its educational bodies, the media, parents, and peers have important roles to play in alleviating this scourge
INDIA
Rising awareness and COVID-19 impact: India's private health insurers see 26% premium surge in August
Analysts cite low COVID-related policy renewals from last year as a reason for the high base this year
BUSINESS
DCGI issues safety alert on falsified lymphoma injections from Takeda
Consumers and patients are advised to be careful and only procure the medical products from authorised sources with proper purchase invoice
INDIA
DCGI issues alert against Abbott’s antacid Digene gel after company initiates voluntary recall
The regulator has asked patients to discontinue the use of Digene Gel products, which were manufactured at the Goa Facility
HEALTH-AND-FITNESS
89% vitiligo patients in India report moderate to high depressive symptoms: Study
The prevalence of a negative perception of vitiligo in India was identified as a possible reason for high mental stress among patients in the country
TRENDS
Bharat Serums to expand women’s health business in Southeast Asia, Africa
The women and critical care segment, which the company focuses on, has unmet needs in these geographies
BUSINESS
Indian Business Family Awards 2022: Dilip Shanghvi, Sun Pharmaceutical’s ray of excellence
The 67-year-old billionaire converted his partnership firm into one of India’s largest pharma manufacturers within three decades. The Reluctant Billionaire’s journey from Rs 10,000 to a market capitalisation of over Rs 2,74,000 crore has few parallels
BUSINESS
Lupin could exceed 18% margin guidance in this financial year: Management
The company plans to launch blockbuster drug Spiriva by the end of the quarter – production, shipments underway
TRENDS
From infectious diarrhoea to IBD dominance: India's health landscape shifts with Western lifestyle uptick: Lancet study
The study, which was conducted in more than 30,000 participants from various districts of Telangana, suggests that urbanisation has had a role to play in this surge of IBD
